Increased detection of the HIV-1 reverse transcriptase M184V mutation using mutation-specific minority assays in a UK surveillance study suggests evidence of unrecognized transmitted drug resistance*
Open Access
- 14 October 2010
- journal article
- Published by Wiley in HIV Medicine
- Vol. 12 (4) , 250-254
Abstract
Objectives The aim of the study was to estimate the levels of transmitted drug resistance (TDR) in HIV‐1 using very sensitive assays to detect minority drug‐resistant populations. Methods We tested unlinked anonymous serum specimens from sexual health clinic attendees, who had not received an HIV diagnosis at the time of sampling, by both standard genotyping and using minority detection assays. Results By standard genotyping, 21 of 165 specimens (12.7%) showed evidence of drug resistance, while, using a combination of standard genotyping and minority mutation assays targeting three commonly observed drug resistance mutations which cause high‐level resistance to commonly prescribed first‐line antiretroviral therapy (ART), this rose to 32 of 165 (19.4%). This increase of 45% in drug resistance levels [95% confidence interval (CI) 15.2–83.7%; P=0.002] was statistically significant. Almost all of this increase was accounted for by additional detections of the M184V mutation. Conclusions Future surveillance studies of TDR in the United Kingdom should consider combining standard genotyping and minority‐specific assays to provide more accurate estimates, particularly when using specimens collected from chronic HIV infections in which TDR variants may have declined to low levels.Keywords
This publication has 14 references indexed in Scilit:
- Does the M184V resistance mutation in reverse transcriptase reduce HIV transmission?*HIV Medicine, 2011
- Drug Resistance Mutations for Surveillance of Transmitted HIV-1 Drug-Resistance: 2009 UpdatePLOS ONE, 2009
- Minority Quasispecies of Drug‐Resistant HIV‐1 That Lead to Early Therapy Failure in Treatment‐Naive and ‐Adherent PatientsClinical Infectious Diseases, 2009
- British HIV Association guidelines for the treatment of HIV‐1‐infected adults with antiretroviral therapy 2008HIV Medicine, 2008
- High prevalence of primary lamivudine and nelfinavir resistance in HIV-1-infected pregnant women in the United States, 1998–2004AIDS, 2007
- Simple PCR Assays Improve the Sensitivity of HIV-1 Subtype B Drug Resistance Testing and Allow Linking of Resistance MutationsPLOS ONE, 2007
- Stability of transmitted drug-resistant HIV-1 speciesCurrent Opinion in Infectious Diseases, 2005
- Performance Characteristics of a New Less Sensitive HIV-1 Enzyme Immunoassay for Use in Estimating HIV SeroincidenceJAIDS Journal of Acquired Immune Deficiency Syndromes, 2003
- HIV-1 drug resistance in primary infections in the UKBMJ, 2001
- The public health applications of unlinked anonymous seroprevalence monitoring for HIV in the United KingdomInternational Journal of Epidemiology, 2000